Skip to main content
. 2017 Sep 1;17:608. doi: 10.1186/s12885-017-3609-6

Fig. 5.

Fig. 5

Cumulative incidence of HCC in at-risk participants. Participants were divided into two groups based on baseline PIVKA-II levels. Cumulative incidences were calculated in all enrolled groups (a) and patients with cirrhosis (b). Dashed lines are interquartile ranges